UnitedHealth Pursuing Payer/Pharma Collaboration To Evaluate Novel Cancer Treatments
Executive Summary
Four drug manufacturers, three payers and one genetics company are close to launching a pilot that provides pharma companies “an environment where they can supply those early testable drugs to patients anywhere with the right set of complex system biology,” UnitedHealthcare Senior VP Lee Newcomer said.